Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype

Abstract Colorectal cancer with chromosomal instability (CIN+) phenotype is immunosuppressive and refractory to immune checkpoint blockade (ICB) therapy. Recently, KIF18A is found to be a mitotic vulnerability in chromosomally unstable cancers, but whether targeting KIF18A affects antitumor immunity...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Liu, Yan Zhang, Zhen Cao, Zhanwei Zhao
Format: Article
Language:English
Published: Nature Publishing Group 2025-04-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02437-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733397034827776
author Gang Liu
Yan Zhang
Zhen Cao
Zhanwei Zhao
author_facet Gang Liu
Yan Zhang
Zhen Cao
Zhanwei Zhao
author_sort Gang Liu
collection DOAJ
description Abstract Colorectal cancer with chromosomal instability (CIN+) phenotype is immunosuppressive and refractory to immune checkpoint blockade (ICB) therapy. Recently, KIF18A is found to be a mitotic vulnerability in chromosomally unstable cancers, but whether targeting KIF18A affects antitumor immunity in CIN+ colorectal cancer is unknown. In our study, western blot, cell viability assay, transwell migration and invasion assays, flow cytometry, animal model, immunohistochemistry (IHC) staining, reverse transcription–quantitative PCR (RT-qPCR) and ELISA assay were conducted to evaluate the potential function of KIF18A in CIN+ colorectal cancer. We found that KIF18A inhibition by short hairpin RNAs (ShRNAs) or small inhibitor AM-1882 suppressed proliferation, migration, invasion and tumor growth and metastasis of CIN+ colorectal cancer cells in vitro and in vivo. Moreover, targeting KIF18A disrupted cell-cycle progression and induced G2/M arrest in CIN+ colorectal cancer cells. In addition, KIF18A inhibition promoted immune infiltration and activation in CIN+ colorectal tumors. KIF18A inhibition suppressed proliferation of Tregs and increased infiltration and activation of cytotoxic CD8+ T cells in CIN+ colorectal tumors. Mechanically, KIF18A inhibition stimulated type I IFN signaling and cGAS-STING activation in CIN+ colorectal tumors. Finally, targeting KIF18A enhanced PD-1 blockade efficiency in CIN+ colorectal tumors through T cells. Our data elucidated a novel role of KIF18A in antitumor immunity of CIN+ colorectal cancer.
format Article
id doaj-art-efe00b9bd7784837acdfd16ca5e8a7df
institution DOAJ
issn 2058-7716
language English
publishDate 2025-04-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-efe00b9bd7784837acdfd16ca5e8a7df2025-08-20T03:08:02ZengNature Publishing GroupCell Death Discovery2058-77162025-04-0111111110.1038/s41420-025-02437-5Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotypeGang Liu0Yan Zhang1Zhen Cao2Zhanwei Zhao3Senior Department of General Surgery, Chinese PLA General HospitalSenior Department of General Surgery, Chinese PLA General HospitalSenior Department of General Surgery, Chinese PLA General HospitalSenior Department of General Surgery, Chinese PLA General HospitalAbstract Colorectal cancer with chromosomal instability (CIN+) phenotype is immunosuppressive and refractory to immune checkpoint blockade (ICB) therapy. Recently, KIF18A is found to be a mitotic vulnerability in chromosomally unstable cancers, but whether targeting KIF18A affects antitumor immunity in CIN+ colorectal cancer is unknown. In our study, western blot, cell viability assay, transwell migration and invasion assays, flow cytometry, animal model, immunohistochemistry (IHC) staining, reverse transcription–quantitative PCR (RT-qPCR) and ELISA assay were conducted to evaluate the potential function of KIF18A in CIN+ colorectal cancer. We found that KIF18A inhibition by short hairpin RNAs (ShRNAs) or small inhibitor AM-1882 suppressed proliferation, migration, invasion and tumor growth and metastasis of CIN+ colorectal cancer cells in vitro and in vivo. Moreover, targeting KIF18A disrupted cell-cycle progression and induced G2/M arrest in CIN+ colorectal cancer cells. In addition, KIF18A inhibition promoted immune infiltration and activation in CIN+ colorectal tumors. KIF18A inhibition suppressed proliferation of Tregs and increased infiltration and activation of cytotoxic CD8+ T cells in CIN+ colorectal tumors. Mechanically, KIF18A inhibition stimulated type I IFN signaling and cGAS-STING activation in CIN+ colorectal tumors. Finally, targeting KIF18A enhanced PD-1 blockade efficiency in CIN+ colorectal tumors through T cells. Our data elucidated a novel role of KIF18A in antitumor immunity of CIN+ colorectal cancer.https://doi.org/10.1038/s41420-025-02437-5
spellingShingle Gang Liu
Yan Zhang
Zhen Cao
Zhanwei Zhao
Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
Cell Death Discovery
title Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
title_full Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
title_fullStr Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
title_full_unstemmed Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
title_short Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
title_sort targeting kif18a triggers antitumor immunity and enhances efficiency of pd 1 blockade in colorectal cancer with chromosomal instability phenotype
url https://doi.org/10.1038/s41420-025-02437-5
work_keys_str_mv AT gangliu targetingkif18atriggersantitumorimmunityandenhancesefficiencyofpd1blockadeincolorectalcancerwithchromosomalinstabilityphenotype
AT yanzhang targetingkif18atriggersantitumorimmunityandenhancesefficiencyofpd1blockadeincolorectalcancerwithchromosomalinstabilityphenotype
AT zhencao targetingkif18atriggersantitumorimmunityandenhancesefficiencyofpd1blockadeincolorectalcancerwithchromosomalinstabilityphenotype
AT zhanweizhao targetingkif18atriggersantitumorimmunityandenhancesefficiencyofpd1blockadeincolorectalcancerwithchromosomalinstabilityphenotype